Bio-Techne
TECH
577 hedge funds and large institutions have $9.52B invested in Bio-Techne in 2025 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 206 increasing their positions, 210 reducing their positions, and 67 closing their positions.
547% more call options, than puts
Call options by funds: $5.54M | Put options by funds: $856K
12% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 67
4.05% more ownership
Funds ownership: 98.67% → 102.72% (+4%)
0% more funds holding
Funds holding: 576 → 577 (+1)
2% less repeat investments, than reductions
Existing positions increased: 206 | Existing positions reduced: 210
16% less capital invested
Capital invested by funds: $11.3B → $9.52B (-$1.78B)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
+$205M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$77.7M |
| 3 |
RC
RGM Capital
Naples,
Florida
|
+$68.5M |
| 4 |
Morgan Stanley
New York
|
+$65.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$48.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$88M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$75.6M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$67.2M |
| 4 |
BAMCO Inc
New York
|
-$58.4M |
| 5 |
Millennium Management
New York
|
-$47.2M |
TECH Hedge Fund Activity: Q1 2025 in Review
577 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2025, worth a combined $9.52B — down 16% from $11.3B a quarter earlier.
Buyers outnumbered sellers: 75 funds opened new TECH positions and 67 closed out — a net gain of 8 holders — while 206 added to existing stakes and 210 trimmed.
The largest buyer was Select Equity Group, adding an estimated $205M. The largest seller was Citadel Advisors, cutting an estimated $88M.
- 577 institutional investors held Bio-Techne (TECH) as of Q1 2025, up from 576 in Q4 2024.
- Funds reported $9.52B of Bio-Techne stock for Q1 2025, down 16% quarter-over-quarter.
- 75 funds opened new Bio-Techne positions in Q1 2025 and 67 closed out, a net change of +8 holders.
- The largest Bio-Techne buyer in Q1 2025 was Select Equity Group, an estimated $205M added.
- The largest Bio-Techne seller in Q1 2025 was Citadel Advisors, an estimated $88M sold.
Based on aggregated 13F filings for Q1 2025.